胃肠病学和肝病学杂志

参考文献

[1]Cotton S,Sharp L,Little J.The adenoma-carcinoma sequence andprospects for the prevention of colorectal neoplasia[J].Crit Rev On-cog,1996,7(5-6):293-342.

[2]Lieberman DA,Weiss DG,Bond JH,et al.Use of colonoscopy toscreen asymptomatic adults for colorectal cancer.Veterans Affairs Co-operative Study Group 380[J].N Engl J Med,2000,343(3):162-168.

[3]Winawer SJ,Zauber AG,Ho MN,et al.Prevention of colorectal cancer bycolonoscopic polypectomy.The National Polyp Study Workgroup[J].NEngl J Med,1993,329(27):1977-1981.

[4]Levin B,Lieberman DA,McFarland B,et al.Screening and surveil-lance for the early detection of colorectal cancer and adenomatous pol-yps,2008:a joint guideline from the American Cancer Society,the USMulti-Society Task Force on Colorectal Cancer,and the American Col-lege of Radiology[J].Gastroenterology,2008,134(5):1570-1595.

[5]Sung JJ,Lau JY,Young GP,et al.Asia Pacific consensus recommen-dations for colorectal cancer screening[J].Gut,2008,57(8):1166-1176.

[6]Yeoh KG,Ho KY,Chiu HM,et al.The Asia-Pacific ColorectalScreening score:a validated tool that stratifies risk for colorectal ad-vanced neoplasia in asymptomatic Asian subjects[J].Gut,2011,60(9):1236-1241.

[7]赵平,陈万青主编.2010中国肿瘤登记年报[M].北京:军事医学科学出版社,2011.

[8]Strul H,Kariv R,Leshno M,et al.The prevalence rate and anatomiclocation of colorectal adenoma and cancer detected by colonoscopy inaverage-risk individuals aged 40-80 years[J].Am J Gastroenterol,2006,101(2):255-262.

[9]Lieberman DA,Prindiville S,Weiss DG,et al.Risk factors for ad-vanced colonic neoplasia and hyperplastic polyps in asymptomatic indi-viduals[J].JAMA,2003,290(22):2959-2967.

[10]Imperiale TF,Glowinski EA,Lin-Cooper C,et al.Five-year risk ofcolorectal neoplasia after negative screening colonoscopy[J].N EnglJ Med,2008,359(12):1218-1224.

[11]Chen HM,Weng YR,Jiang B,et al.Colonoscopy Findings of Color-ectal Adenoma and Cancer in Symptomatic Patients in China between1990 and 2009[J].J Dig Dis,2011,12(10):371-378.

[12]Rundle AG,Lebwohl B,Vogel R,et al.Colonoscopic screening inaverage-risk individuals ages 40 to 49 vs 50 to 59 years[J].Gastro-enterology,2008,134(5):1311-1315.

[13]Hamilton SR,Rubio CA,Vogelstein B,et al.Tumors of the colonand rectum:Carcinoma of the colon and rectum[M].in:HamiltonSR,Aaltonen LA.World Health Organization Classification ofTumours:Pathology and genetics of tumours of the digestive system.3rd ed.Lyon:IARC Press,2000:105-119.

[14]Odze RD,Krieken JH,Riddell RH,et al.Premalignant lesions ofthe digestive system[M].In:Bosman FT,Carneiro F,Hruban RH,et al.WHO Classification of Tumors of the Digestive System.4th ed.Lyon:IARC Press,2010:132-146.

[15]Xu F,Xu J,Lou Z,et al.Micropapillary component in colorectalcarcinoma is associated with lymph node metastasis in T1 and T2 sta-ges and decreased survival time in TNM stages I and II[J].Am JSurg Pathol,2009,33(9):1287-1292.

[16]Ogawa T,Yoshida T,Tsuruta T,et al.Tumor budding is predictiveof lymphatic involvement and lymph node metastases in submucosalinvasive colorectal adenocarcinomas and in non-polypoid comparedwith polypoid growths[J].Scand J Gastroenterol,2009,44(5):605-614.

[17]Tanaka M,Hashiguchi Y,Ueno H,et al.Tumor budding at the inva-sive margin can predict patients at high risk of recurrence after cura-tive surgery for stage II,T3 colon cancer[J].Dis Colon Rectum,2003,46(8):1054-1059.

[18]徐芳英,董健康,朱益民,等.结直肠癌独立预后因素:TNM分期、肿瘤芽、神经周围侵犯、瘤旁淋巴细胞浸润和尿糖[J].中华流行病学杂志,2005,26(5):366-369.

[19]万德森主编.NCCN肿瘤学临床实践指南(结直肠癌)[M].第1版.2009年.

[20]Morson BC.Gastreintestinal Pathologp[M].2nd ed.1979:607-609,637-638.

[21]Bosman FT,Carneiro F,Hruban RH.WHO classification of tumoursof the digestive system[M].4th ed.International Agency for Re-search on Cancer,2101:147.

[22]来茂德,滕晓东,徐芳英.胃肠道病理研究的一些共识和争议[J].中华病理学杂志,2011,40(5):289-292.

[23]Screening for colorectal cancer:U.S.Preventive Services Task Forcerecommendation statement[J].Ann Intern Med,2008,149(9):627-637.

[24]Lieberman DA,Weiss DG.One-time screening for colorectal cancerwith combined fecal occult-blood testing and examination of the distalcolon[J].N Engl J Med,2001,345(8):555-560.

[25]Allison JE,Tekawa IS,Ransom LJ,et al.A comparison of fecal oc-cult-blood tests for colorectal-cancer screening[J].N Engl J Med,1996,334(3):155-159.

[26]Allison JE,Sakoda LC,Levin TR,et al.Screening for colorectal ne-oplasms with new fecal occult blood tests:update on performancecharacteristics[J].J Natl Cancer Inst,2007,99(19):1462-1470.

[27]Meng W,Cai SR,Zhou L,et al.Performance value of high risk fac-tors in colorectal cancer screening in China[J].World J Gastroen-terol,2009,15(48):6111-6116.

[28]张亚历,周殿元.肠镜检查在早期大肠癌诊断中的重要作用[J].世界华人消化杂志,2003,11(5):640-642.

[29]Hilsden R,Rostom A.Colorectal cancer screening using flexible sig-moidoscopy:United Kingdom study demonstrates significant incidenceand mortality benefit[J].Can J Gastroenterol,2010,24(8):479-480.

[30]Zheng S,Liu XY,Ding KF,et al.Reduction of the incidence andmortality of rectal cancer by polypectomy:a prospective cohort study inHaining County[J].World J Gastroenterol,2002,8(3):488-492.

[31]Levin B,Lieberman DA,McFarland B,et al.Screening and surveil-lance for the early detection of colorectal cancer and adenomatous pol-yps,2008:a joint guideline from the American Cancer Society,theUS Multi-Society Task Force on Colorectal Cancer,and the AmericanCollege of Radiology[J].CA Cancer J Clin,2008,58(3):130-160.

[32]陈坤,俞维萍,马新源,等.结直肠癌个体危险度及人群筛检数量化评价的研究[J].肿瘤,2005,25(1):66-70.

[33]陈坤,焦登鳌.人群大肠癌筛检数量化方法的应用研究[J].中华肿瘤杂志,1993,15(1):37-40.

[34]Harnett SJ,Wong SK,Lackey GW.Opportunistic GP-based bowelcancer screening[J].Med J Aust,2003,178(2):92-93.

[35]中国国家卫生部.2006年中国卫生统计提要[S].2007.

[36]马新源,李其龙,马万里.大肠癌筛查的成本测算及成本控制[J].中国肿瘤,2011,20(6):422-424.

[37]韩英,武子涛,李世荣.应倡导大肠肿瘤的"伺机性筛查"[J].中华内科杂志,2008,47(9):725-756.

[38]韩英,武子涛,李世荣,等.伺机性筛查2756例大肠肿瘤结果分析[J].中国误诊学杂志,2008,8(9):2130-2130.

[39]韩英,武子涛,盛剑秋,等.大肠肿瘤伺机性筛查的临床应用探讨[J].中华内科杂志,2010,49(7):618-619.

[40]Chu E.Colorectal cancer screening and early detection[J].ClinColorectal Cancer,2010,9(2):75-76.

[41]李世荣.现阶段我国大肠癌筛查策略的思考[J].胃肠病学和肝病学杂志,2008,17(4):261-262.

[42]Hobbs FD,Cherry RC,Fielding JW,et al.Acceptability of oppor-tunistic screening for occult gastrointestinal blood loss[J].BMJ,1992,304(6825):483-486.

[43]Yeoh KG,Chew L,Wang SC.Cancer screening in Singapore,with parti-cular reference to breast,cervical and colorectal cancer screening[J].JMed Screen,2006,13 Suppl 1:S14-S19.

[44]武子涛,王志红.再论序贯法粪隐血试验初筛大肠肿瘤的价值[J].实用肿瘤杂志,1995,10(4):223-224.

[45]李世荣.华北部分地区大肠癌抽样普查分析[J].解放军医学杂志,1990,15(1):30-32.

[46]李世荣,田素丽,武子涛,等.序贯粪隐血试验在自然人群连续性大肠癌普查中的应用[J].世界华人消化杂志,2004,12(1):137-139.

[47]金鹏,盛剑秋,武子涛,等.自然人群序贯粪隐血试验连续性结直肠癌普查的队列研究:19年结果分析[J].胃肠病学,2008,13(1):4-8.

[48]郑树,张苏展,蔡善荣,等.大肠癌筛查方案及其实践[J].中国肿瘤,2009,18(9):700-704.

[49]郑树,杨工,余海,等.早期大肠癌筛查暨人群无症状结肠癌筛检方案的重复验证[J].医学研究通讯,1992,21(4):30-31.

[50]郑树.大肠癌高发现场病因、筛查方法及早诊早治研究[J].中国肿瘤,1996,5(5):18-19.

[51]Engel C,Rahner N,Schulmann K,et al.Efficacy of annual colono-scopic surveillance in individuals with hereditary nonpolyposis colorec-tal cancer[J].Clin Gastroenterol Hepatol,2010,8(2):174-182.

[52]Capelle LG,Van Grieken NC,Lingsma HF,et al.Risk and epidemi-ological time trends of gastric cancer in Lynch syndrome carriers in theNetherlands[J].Gastroenterology,2010,138(2):487-492.

[53]Burt R,Neklason DW.Genetic testing for inherited colon cancer[J].Gastroenterology,2005,128(6):1696-1716.

[54]NCCN Guidelines Version2.Colorectal Cancer Screening.2011.

[55]Eaden JA,Abrams KR,Mayberry JF.The risk of colorectal cancer inulcerative colitis:a meta-analysis[J].Gut,2001,48(4):526-535.

[56]Obrador A,Ginard D,Barranco L.Review article:colorectal cancersurveillance in ulcerative colitis-what should we be doing[J]?Ali-ment Pharmacol Ther,2006,24 Suppl 3:56-63.

[57]Efthymiou M,Taylor AC,Kamm MA.Cancer surveillance strategiesin ulcerative colitis:the need for modernization[J].Inflamm BowelDis,2011,17(8):1800-1813.

[58]National Institute for Health and Clinical Excellence.Colonoscopicsurveillance for prevention of colorectal cancer in people with ulcera-tive colitis,Crohn's disease or adenomas.NICE clinical guideline118.March 2011.

[59]Rutter MD,Saunders BP,Wilkinson KH,et al.Thirty-year analysis of acolonoscopic surveillance program for neoplasia in ulcerative colitis[J].Gastroenterology,2006,130(4):1030-1038.

[60]Velayos FS,Liu L,Lewis JD,et al.Prevalence of colorectal cancersurveillance for ulcerative colitis in an integrated health care deliverysystem[J].Gastroenterology,2010,139(5):1511-1518.

[61]Brackmann S,Andersen SN,Aamodt G,et al.Relationship betweenclinical parameters and the colitis-colorectal cancer interval in a cohortof patients with colorectal cancer in inflammatory bowel disease[J].Scand J Gastroenterol,2009,44(1):46-55.

[62]Delaunoit T,Limburg PJ,Goldberg RM,et al.Colorectal cancerprognosis among patients with inflammatory bowel disease[J].ClinGastroenterol Hepatol,2006,4(3):335-342.

[63]Allen PB,Kamm MA,De Cruz P,et al.Dysplastic lesions in ulcera-tive colitis:changing paradigms[J].Inflamm Bowel Dis,2010,16(11):1978-1983.

[64]Averboukh F,Ziv Y,Kariv Y,et al.Colorectal carcinoma in inflam-matory bowel disease:a comparison between Crohn's and ulcerativecolitis[J].Colorectal Dis,2011,13:1230-1236.

[65]Ullman T,Odze R,Farraye FA.Diagnosis and management of dysplasiain patients with ulcerative colitis and Crohn’s disease of the colon[J].Inflamm Bowel Dis,2009,15:630-638.

[66]Ohnishi T,Watanabe T,Nozawa H,et al.Telomerase activity ofblood samples and recurrence of colorectal cancer[J].Hepatogastro-enterology,2008,55(86-87):1513-1518.

[67]Lledo SM,Garcia-Granero E,Dasi F,et al.Real time quantificationin plasma of human telomerase reverse transcriptase(hTERT)mRNAin patients with colorectal cancer[J].Colorectal Dis,2004,6(4):236-242.

[68]Sidransky D,Tokino T,Hamilton SR,et al.Identification of ras onco-gene mutations in the stool of patients with curable colorectal tumors[J].Science,1992,256(5053):102-105.

[69]Nollau P,Moser C,Weinland G,et al.Detection of K-ras mutations instools of patients with colorectal cancer by mutant-enriched PCR[J].IntJ Cancer,1996,66(3):332-336.

[70]Smith-Ravin J,England J,Talbot IC,et al.Detection of c-Ki-rasmutations in faecal samples from sporadic colorectal cancer patients[J].Gut,1995,36(1):81-86.

[71]Eguchi S,Kohara N,Komuta K,et al.Mutations of the p53gene inthe stool of patients with resectable colorectal cancer[J].Cancer,1996,77(8 Suppl):1707-1710.

[72]Traverso G,Shuber A,Levin B,et al.Detection of APC mutations infecal DNA from patients with colorectal tumors[J].N Engl J Med,2002,346(5):311-320.

[73]Sheng JQ,Li SR,Wu ZT,et al.Transferrin dipstick as a potentialnovel test for colon cancer screening:a comparative study with immu-no fecal occult blood test[J].Cancer Epidemiol Biomarkers Prev,2009,18(8):2182-2185.

[74]Rajapaksa RC,Macari M,Bini EJ.Prevalence and impact of extraco-lonic findings in patients undergoing CT colonography[J].J ClinGastroenterol,2004,38(9):767-771.

[75]Pickhardt PJ,Hassan C,Halligan S,et al.Colorectal cancer:CTcolonography and colonoscopy for detection-systematic review and me-ta-analysis[J].Radiology,2011,259(2):393-405.

[76]Belsey J,Epstein O,Heresbach D.Systematic review:oral bowelpreparation for colonoscopy[J].Aliment Pharmacol Ther,2007,25(4):373-384.

[77]Harewood GC,Sharma VK,de Garmo P.Impact of colonoscopy prep-arationquality on detection of suspected colonic neoplasia[J].Gas-trointest Endosc,2003,58(1):76-79.

[78]Froehlich F,Wietlisbach V,Gonvers JJ,et al.Impact of coloniccleansing onquality and diagnostic yield of colonoscopy:the EuropeanPanel of Appropriatenessof Gastrointestinal Endoscopy European mul-ticenter study[J].Gastrointest Endosc,2005,61(3):378-384.

[79]黄应龙,智发朝,黄丽韫,等.结肠镜检查中大肠腺瘤的漏诊率及漏诊相关危险因素[J].中华消化内镜杂志,2010,27(6):281-286.

[80]Simmons DT,Harewood GC,Baron TH,et al.Impact of endoscopistwithdrawal speed on polyp yield:implications for optimal colonoscopywithdrawal time[J].Aliment Pharmacol Ther,2006,24(6):965-971.

[81]The Paris endoscopic classification of superficial neoplastic lesions:e-sophagus,stomach,and colon:November 30 to December 1,2002[J].Gastrointest Endosc,2003,58(6 Suppl):S3-S43.

[82]姜泊.染色内镜和放大内镜的应用是提高早期大肠癌诊治水平的重要手段[J].中华消化内镜杂志,2005,22(5):293-294.

[83]姜泊,智发朝,刘思德,等.采用腺管开口分型和内镜黏膜切除术诊治大肠肿瘤[J].中华医学杂志,2003,83(4):294-297.

[84]Kudo S.Early colorectal cancer-detection of depressed types of color-ectal carcinoma[M].Igaku-Shoin Medical Publisher,Inc.Tokyo,1996:50-51.

[85]中华医学会消化内镜学分会肠道学组,姜泊,刘思德.中国早期大肠癌内镜诊治共识意见(天津,2008年8月30日)[J].中华消化内镜杂志,2008,25(12):321-324.

[86]Togashi K,Hewett DG,Whitaker DA,et al.The use of acetic acidin magnification chromocolonoscopy for pit pattern analysis of smallpolyps[J].Endoscopy,2006,38(6):613-616.

[87]Matsuda T,Fujii T,Saito Y,et al.Efficacy of the invasive/non-inva-sive pattern by magnifying chromoendoscopy to estimate the depth ofinvasion of early colorectal neoplasms[J].Am J Gastroenterol,2008,103(11):2700-2706.

[88]Sakamoto T,Saito Y,Nakajima T,et al.Comparison of magnifyingchromoendoscopy and narrow-band imaging in estimation of early colo-rectal cancer invasion depth:a pilot study[J].Dig Endosc,2011,23(2):118-123.

[89]Saitoh Y,Obara T,Watari J,et al.Invasion depth diagnosis of de-pressed type early colorectal cancers by combined use of videoendosco-py and chromoendoscopy[J].Gastrointest Endosc,1998,48(4):362-370.

[90]Sano Y,Horimatsu T,Fu KI,et al.Magnifying observation of micro-vascular architecture of colorectal lesions using narrow band imagingsystem[J].Dig Endosc,2006,18:S44-S51.

[91]Wada Y,Kudo SE,Misawa M,et al.Vascular pattern classification ofcolorectal lesions with narrow band imaging magnifying endoscopy[J].Dig Endosc,2011,23 Suppl 1:106-111.

[92]Kanao H,Tanaka S,Oka S,et al.Narrow-band imaging magnifica-tion predicts the histology and invasion depth of colorectal tumors[J].Gastrointest Endosc,2009,69(3 Pt 2):631-636.

[93]Puli SR,Bechtold ML,Reddy JB,et al.Can endoscopic ultrasoundpredict early rectal cancers that can be resected endoscopically?A me-ta-analysis and systematic review[J].Dig Dis Sci,2010,55(5):1221-1229.

[94]Hoffman A,Sar F,Goetz M,et al.High definition colonoscopy com-bined with i-Scan is superior in the detection of colorectal neoplasiascompared with standard video colonoscopy:a prospective randomizedcontrolled trial[J].Endoscopy,2010,42(10):827-833.

[95]Lee CK,Lee SH,Hwangbo Y.Narrow-band imaging versus I-Scanfor the real-time histological prediction of diminutive colonic polyps:aprospective comparative study by using the simple unified endoscopicclassification[J].Gastrointest Endosc,2011,74(3):603-609.

[96]Hoffman A,Kagel C,Goetz M,et al.Recognition and characteriza-tion of small colonic neoplasia with high-definition colonoscopy usingi-Scan is as precise as chromoendoscopy[J].Dig Liver Dis,2011,42(1):45-50.

[97]Kiesslich R,Burg J,Vieth M,et al.Confocal laser endoscopy for di-agnosing intraepithelial neoplasias and colorectal cancer in vivo[J].Gastroenterology,2004,127(3):706-713.

[98]Kashida H,Kudo SE.Early colorectal cancer:concept,diagnosis,and management[J].Int J Clin Oncol,2006,11(1):1-8.

[99]Cappell MS,Friedel D.The role of sigmoidoscopy and colonoscopy inthe diagnosis and management of lower gastrointestinal disorders:technique,indications,and contraindications[J].Med Clin NorthAm,2002,86(6):1217-1252.

[100]Tanaka S,Oka S,Chayama K.Colorectal endoscopic submucosaldissection:present status and future perspective,including its differ-entiation from endoscopic mucosal resection[J].J Gastroenterol,2008,43(9):641-651.

[101]Tanaka S,Haruma K,Oka S,et al.Clinicopathologic features andendoscopic treatment of superficially spreading colorectal neoplasmslarger than 20 mm[J].Gastrointest Endosc,2001,54(1):62-66.

[102]Huang Y,Liu S,Gong W,et al.Clinicopathologic features and en-doscopic mucosal resection of laterally spreading tumors:experiencefrom China[J].Int J Colorectal Dis,2009,24(12):1441-1450.

[103]Hu JJ,Wang X,Pan X,et al.An increase in the diagnosis rate ofearly colorectal cancer by sample targeting using stereomicroscopy:atwo-year experience with 196 cases[J].Hepatogastroenterology,2008,55(86-87):1578-1583.

[104]Martinez ME,Sampliner R,Marshall JR,et al.Adenoma character-istics as risk factors for recurrence of advanced adenomas[J].Gas-troenterology,2001,120(5):1077-1083.

[105]Martinez ME,Baron JA,Lieberman DA,et al.A pooled analysis ofadvanced colorectal neoplasia diagnoses after colonoscopic polypecto-my[J].Gastroenterology,2009,136(3):832-841.

[106]Gao QY,Chen HM,Sheng JQ,et al.The first year follow-up aftercolorectal adenoma polypectomy is important:a multiple-center studyin symptomatic hospital-based individuals in China[J].Front MedChina,2010,4(4):436-442.

[107]Kaminski MF,Regula J,Kraszewska E,et al.Quality indicators forcolonoscopy and the risk of interval cancer[J].N Engl J Med,2010,362(19):1795-1803.

[108]Sawhney MS,Farrar WD,Gudiseva S,et al.Microsatellite instabil-ity in interval colon cancers[J].Gastroenterology,2006,131(6):1700-1705.

[109]Pabby A,Schoen RE,Weissfeld JL,et al.Analysis of colorectalcancer occurrence during surveillance colonoscopy in the dietary pol-yp prevention trial[J].Gastrointest Endosc,2005,61(3):385-391.

[110]Winawer SJ,Zauber AG,Fletcher RH,et al.Guidelines forcolonoscopy surveillance after polypectomy:a consensus update bythe US Multi-Society Task Force on Colorectal Cancer and the Ameri-can Cancer Society[J].Gastroenterology,2006,130(6):1872-1885.

[111]房静远.大肠癌的化学预防:问题与希望并存[J].中华内科杂志,2009,48(2):93-94.

[112]Sung JJ,Lau JY,Goh KL,et al.Increasing incidence of colorectalcancer in Asia:implications for screening[J].Lancet Oncol,2005,6(11):871-876.

[113]Heresbach D,Barrioz T,Lapalus MG,et al.Miss rate for colorectalneoplastic polyps:a prospective multicenter study of back-to-backvideo colonoscopies[J].Endoscopy,2008,40(4):284-290.

[114]房静远,沈镭,孙丹凤.大肠癌高危人群:筛查和预防的重点[J].中华医学杂志,2009,89(20):1369-1371.

[115]房静远.关注结直肠腺瘤的诊治研究[J].中华消化杂志,2010,30(7):433-435.

[116]房静远.结直肠腺瘤癌变及其预防[J].中华消化杂志,2011,31(2):136-137.

[117]Thompson PA,Gerner EW.Current concepts in colorectal cancerprevention[J].Expert Rev Gastroenterol Hepatol,2009,3(4):369-382.

[118]Sporn MB,Dunlop NM,Newton DL,et al.Prevention of chemical car-cinogenesis by vitamin A and its synthetic analogs(retinoids)[J].FedProc,1976,35(6):1332-1338.

[119]Bingham SA,Day NE,Luben R,et al.Dietary fibre in food andprotection against colorectal cancer in the European Prospective Investi-gation into Cancer and Nutrition(EPIC):an observational study[J].Lancet,2003,361(9368):1496-1501.

[120]Peters U,Sinha R,Chatterjee N,et al.Dietary fibre and colorectaladenoma in a colorectal cancer early detection programme[M].Lancet,2003,361(9368):1491-1495.

[121]Jacobs ET,Haussler MR,Martínez ME.Vitamin D activity and color-ectal neoplasia:a pathway approach to epidemiologic studies[J].Cancer Epidemiol Biomarkers Prev,2005,14(9):2061-2063.

[122]Pufulete M.Intake of dairy products and risk of colorectal neoplasia[J].Nutr Res Rev,2008,21(1):56-67.

[123]Mizoue T,Kimura Y,Toyomura K,et al.Calcium,dairy foods,vi-tamin D,and colorectal cancer risk:the Fukuoka Colorectal CancerStudy[J].Cancer Epidemiol Biomarkers Prev,2008,17(10):2800-2807.

[124]de Vogel S,Dindore V,van Engeland M,et al.Dietary folate,me-thionine,riboflavin,and vitamin B-6 and risk of sporadic colorectalcancer[J].J Nutr,2008,138(12):2372-2378.

[125]Wolpin BM,Wei EK,Ng K,et al.Prediagnostic plasma folate andthe risk of death in patients with colorectal cancer[J].J Clin On-col,2008,26(19):3222-3228.

[126]Stevens VL,McCullough ML,Sun J,et al.High levels of folate fromsupplements and fortification are not associated with increased risk ofcolorectal cancer[J].Gastroenterology,2011,141(1):98-105.

[127]Lee JE,Willett WC,Fuchs CS,et al.Folate intake and risk ofcolorectal cancer and adenoma:modification by time[J].Am J ClinNutr,2011,93(4):817-825.

[128]Alberts DS,Martinez ME,Roe DJ,et al.Lack of effect of a high-fi-ber cereal supplement on the recurrence of colorectal adenomas.Phoenix Colon Cancer Prevention Physicians'Network[J].N Engl JMed,2000,342(16):1156-1162.

[129]Schatzkin A,Lanza E,Corle D,et al.Lack of effect of a low-fat,high-fiber diet on the recurrence of colorectal adenomas.Polyp Pre-vention Trial Study Group[J].N Engl J Med,2000,342(16):1149-1155.

[130]Crott JW,Choi SW,Ordovas JM,et al.Effects of dietary folate andaging on gene expression in the colonic mucosa of rats:implicationsfor carcinogenesis[J].Carcinogenesis,2004,25(1):69-76.

[131]Cole BF,Baron JA,Sandler RS,et al.Folic acid for the preventionof colorectal adenomas:a randomized clinical trial[J].JAMA,2007,297(21):2351-2359.

[132]Logan RF,Grainge MJ,Shepherd VC,et al.Aspirin and folic acidfor the prevention of recurrent colorectal adenomas[J].Gastroenter-ology,2008,134(1):29-38.

[133]Ibrahim EM,Zekri JM.Folic acid supplementation for the preven-tion of recurrence of colorectal adenomas:metaanalysis of interven-tional trials[J].Med Oncol,2010,27(3):915-918.

[134]Lynch PM.Prevention of colorectal cancer in high-risk populations:the increasing role for endoscopy and chemoprevention in FAP andHNPCC[J].Digestion,2007,76(1):68-76.

[135]Chan AT,Giovannucci EL,Meyerhardt JA,et al.Aspirin dose andduration of use and risk of colorectal cancer in men[J].Gastroen-terology,2008,134(1):21-28.

[136]Dube C,Rostom A,Lewin G,et al.The use of aspirin for primaryprevention of colorectal cancer:a systematic review prepared for theU.S.Preventive Services Task Force[J].Ann Intern Med,2007,146(5):365-375.

[137]Cook NR,Lee IM,Gaziano JM,et al.Low-dose aspirin in the pri-mary prevention of cancer:the Women's Health Study:a randomizedcontrolled trial[J].JAMA,2005,294(1):47-55.

[138]Din FV,Theodoratou E,Farrington SM,et al.Effect of aspirin andNSAIDs on risk and survival from colorectal cancer[J].Gut,2010,59(12):1670-1679.

[139]Winawer SJ,Zauber AG.Colonoscopic polypectomy and the inci-dence of colorectal cancer[J].Gut,2001,48(6):753-754.

[140]Bertagnolli MM,Eagle CJ,Zauber AG,et al.Celecoxib for the pre-vention of sporadic colorectal adenomas[J].N Engl J Med,2006,355(9):873-884.

[141]Arber N,Eagle CJ,Spicak J,et al.Celecoxib for the prevention ofcolorectal adenomatous polyps[J].N Engl J Med,2006,355(9):885-895.

[142]Baron JA,Sandler RS,Bresalier RS,et al.A randomized trial ofrofecoxib for the chemoprevention of colorectal adenomas[J].Gas-troenterology,2006,131(6):1674-1682.

[143]Bertagnolli MM.Chemoprevention of colorectal cancer with cyclooxy-genase-2 inhibitors:two steps forward,one step back[J].LancetOncol,2007,8(5):439-443.

[144]Rostom A,Dube C,Lewin G,et al.Nonsteroidal anti-inflammatorydrugs and cyclooxygenase-2 inhibitors for primary prevention of color-ectal cancer:a systematic review prepared for the U.S.PreventiveServices Task Force[J].Ann Intern Med,2007,146(5):376-389.

[145]Fang JY,Chen YX,Lu J,et al.Epigenetic modification regulatesexpression of tumor-associated genes and cell cycle in human coloncancer cell lines Colo-320 and SW1116[J].Cell Res,2004,13(3):217-226.

[146]房静远,萧树东.生物活性食物成分预防大肠癌的发生[J].中华消化杂志,2006,26(10):716-717.

[147]Bhatnagar N,Li X,Chen Y,et al.3,3'-diindolylmethane enhancesthe efficacy of butyrate in colon cancer prevention through down-reg-ulation of survivin[J].Cancer Prev Res(Phila),2009,2(6):581-589

[148]Crim KC,Sanders LM,Hong MY,et al.Upregulation of p21Waf1/Cip1 expression in vivo by butyrate administration can be chemopro-tective or chemopromotive depending on the lipid component of thediet[J].Carcinogenesis,2008,29(7):1415-1420.

[149]Grau MV,Baron JA,Sandler RS,et al.Vitamin D,calcium sup-plementation,and colorectal adenomas:results of a randomized trial[J].J Natl Cancer Inst,2003,95(23):1765-1771.

[150]Wang JL,Lin YW,Chen HM,et al.Calcium prevents tumorigene-sis in a mouse model of colorectal cancer[J].PLoS One,2011,6(8):22566.

[151]Grau MV,Rees JR,Baron JA.Chemoprevention in gastrointestinalcancers:current status[J].Basic Clin Pharmacol Toxicol,2006,98(3):281-287.

[152]Pufulete M.Intake of dairy products and risk of colorectal neoplasia[J].Nutr Res Rev,2008,21(1):56-67.

[153]Lu R,Wang X,Sun DF,et al.Folic acid and sodium butyrate pre-vent tumorigenesis in a mouse model of colorectal cancer[J].Epi-genetics,2008,3(6):330-335.

[154]Corfe BM,Williams EA,Bury JP,et al.A study protocol to investi-gate the relationship between dietary fibre intake and fermentation,colon cell turnover,global protein acetylation and early carcinogene-sis:the FACT study[J].BMC Cancer,2009,9:332.

[155]Hallert C,Bjrck I,Nyman M,et al.Increasing fecal butyrate inulcerative colitis patients by diet:controlled pilot study[J].In-flamm Bowel Dis,2003,9(2):116-121.

[156]Vernia P,Monteleone G,Grandinetti G,et al.Combined oral sodi-um butyrate and mesalazine treatment compared to oral mesalazine a-lone in ulcerative colitis:randomized,double-blind,placebo-con-trolled pilot study[J].Dig Dis Sci,2000,45(5):976-981.

[157]Uraoka T,Saito Y,Ikematsu H,et al.Sano's capillary pattern clas-sification for narrow-band imaging of early colorectal lesions[J].Dig Endosc,2011,23 Suppl 1:112-115

[158]Cairns SR,Scholefield JH,Steele RJ,et al.Guidelines for colorec-tal cancer screening and surveillance in moderate and high riskgroups(update from 2002)[J].Gut,2010,59(5):666-689.